Giá hiện tại
Alopexx, Inc., a clinical stage biotechnology company, focusing on developing novel immune therapeutics for the prevention, treatment, and mitigation of bacterial, fungal, and parasitic infections. The company is headqua...|
e.g. Promoter holding
Loading chart...
Dự báo EPS và doanh thu theo đồng thuận của các nhà phân tích.
Dữ liệu dự báo lợi nhuận cho công ty này hiện không có.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | TTRADESTATI... | TRAD | $147.69M | 126.12 | 1.27 | — | — | — | — |
| 2. | TTRADESTATI... | TRAD | $147.69M | 126.12 | 1.27 | — | — | — | — |
| 3. | AAperture A... | APUR | $148.37M | — | — | — | — | — | — |
| 4. | NSouthern C... | NCO | $146.85M | — | — | — | — | — | — |
| 5. | XXFLH Capit... | XFLH | $146.33M | — | — | — | — | — | — |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Quarter (M) | Sep 21 | Dec 21 | Mar 22 | Jun 22 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
COGS | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 |
Gross Profit % | - | - | - | - |
| 0 | 0 | 0.49 | 0.52 | |
EBIT | 0 | 0 | -0.49 | -0.52 |
OPM % | - | - | - | - |
Non-Operating Income | 0 | 0 | -0.01 | -0.02 |
PBT | 0 | 0 | -0.5 | -0.54 |
Income Tax | 0 | 0 | 0 | 0 |
Tax Rate % | - | - | - | - |
Net Income | 0 | 0 | -0.5 | -0.54 |
NPM % | - | - | - | - |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 |
|---|---|---|---|
Revenue | 0 | 0 | 0 |
COGS | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 |
Gross Profit % | - | - | - |
| 0 | 1.67 | 0.9 | |
EBIT | 0 | -1.67 | -0.9 |
OPM % | - | - | - |
Non-Operating Income | 0 | -0.03 | -0.05 |
PBT | 0 | -1.7 | -0.96 |
Income Tax | 0 | 0 | 0 |
Tax Rate % | - | - | - |
Net Income | 0 | -1.7 | -0.96 |
NPM % | - | - | - |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 |
|---|---|---|---|
| 0 | 0.02 | 0.04 | |
| 0 | 0 | 0 | |
| 0 | 0 | 0 | |
| 1.3 | 0.04 | 0.11 | |
| 0 | 0 | 0 | |
Total Assets | 0 | 0.06 | 0.15 |
| 0 | 0 | 0 | |
| -2.29 | -1.07 | -0.74 | |
| 0 | 0.8 | 0.2 | |
| 0.66 | 0 | 0.5 | |
| 0 | 0.33 | 0.19 | |
Total Liabilities | 0 | 0.06 | 0.15 |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2019 | Dec 2020 | Dec 2021 |
|---|---|---|---|
| -1.62 | -2.07 | -0.28 | |
| 0 | 0 | 0 | |
| 2.92 | 0.8 | 0.3 | |
Net CFNet Cash Flow | 1.29 | -1.27 | 0.02 |
FCFFree Cash Flow | -1.62 | -2.07 | -0.28 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2019 | Dec 2020 | Dec 2021 |
|---|---|---|---|
| - | - | 105.6% | |
| - | -0.56 | -0.27 | |
| 1.95 | 0.12 | 0.22 | |
| - | - | 0.00 | |
Cash Conversion | - | 1.22 | 0.29 |
Payout Ratio | - | - | - |
| - | - | - | |
| - | - | - | |
| - | - | - | |
| 1.00 | 1.00 | 5.00 | |
| - | - | - | |
| - | - | - | |
| - | - | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Ai sở hữu Alpex Acquisition Corp - Class A, theo hồ sơ SEC
Shares sold short · updated twice a month
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 733 | -99.1% | 1.00 | |
| 15 Oct 2026 | 80,484 | +62290.7% | 2.10 | |
| 30 Sep 2026 | 129 | -79.1% | 1.00 | |
| 15 Sep 2026 | 616 | -28.3% | 1.00 | |
| 31 Aug 2026 | 859 | +813.8% | 1.00 | |
| 14 Aug 2026 | 94 | +118.6% | 1.00 | |
| 31 Jul 2026 | 43 | -99.9% | 1.00 | |
| 15 Jul 2026 | 32,063 | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
Hồ sơ SEC và bản ghi cuộc gọi kết quả kinh doanh của Alpex Acquisition Corp - Class A
What recent news says about Alpex Acquisition Corp - Class A, scored for sentiment.